Acellular pertussis vaccine

• 收藏
• 分享

专利权人:

JANSSEN VACCINES & PREVENTION B.V.

发明人:

Poolman Jan Theunis

申请号：

NZ63086814

公开号：

NZ630868A

申请日:

2014.03.06

申请国别(地区):

NZ

年份:

2017

代理人:

摘要：

Disclosed is an acellular pertussis (aP) vaccine composition comprising Bordetella pertussis antigens, pertussis toxoid (PT), filamentous haemagglutinin (FHA), and fimbriae types 2 and 3 (FIM), wherein FIM is present in an amount 5 of 12-100 μg per human dose. Also disclosed is the use of said composition in the manufacture of a vaccine for vaccinating a subject against Bordetella pertussis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/